片頭痛治療の世界市場 2020年

• 英文タイトル：Global Migraine Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114544 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、片頭痛治療の世界市場を調査対象にし、片頭痛治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（特定抗片頭痛薬、急性療法、予防療法、その他）、用途別分析（病院、クリニック、家庭用、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Allergan、GlaxoSmithKline、Teva、Merck、Endo International、Pfizer、Abbott、Johnson & Johnson、Amgen、Impax、Kowa Pharmaceuticals America、Amirall、Bayer、Revance Therapeutics、Winston Pharmaceuticals、Ethypharm、Eli Lilly、OptiNose、AstraZeneca、Novartis International、RedHill Biopharma、Valeant Pharma、Eisai、Biohaven Pharma、Bausch Health、NeurAxon ・企業別売上、市場シェア ・片頭痛治療の地域別市場分析 ・片頭痛治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・片頭痛治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・片頭痛治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・片頭痛治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・片頭痛治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・片頭痛治療の種類別市場規模2015-2020：特定抗片頭痛薬、急性療法、予防療法、その他 ・片頭痛治療の用途別市場規模2015-2020：病院、クリニック、家庭用、その他 ・片頭痛治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Migraine Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Migraine Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Migraine Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Migraine Therapeutics market has been segmented into:
Specific Anti-migraine Drugs
Acute Therapies
Preventative Therapies
Other

By Application, Migraine Therapeutics has been segmented into:
Hospitals
Clinics
Household Use
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Migraine Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Migraine Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Migraine Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Migraine Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Migraine Therapeutics Market Share Analysis
Migraine Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Migraine Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Migraine Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Migraine Therapeutics are:
Allergan
GlaxoSmithKline
Teva
Merck
Endo International
Pfizer
Abbott
Johnson & Johnson
Amgen
Impax
Kowa Pharmaceuticals America
Amirall
Bayer
Revance Therapeutics
Winston Pharmaceuticals
Ethypharm
Eli Lilly
OptiNose
AstraZeneca
Novartis International
RedHill Biopharma
Valeant Pharma
Eisai
Biohaven Pharma
Bausch Health
NeurAxon

レポート目次

---

Table of Contents

1 Migraine Therapeutics Market Overview
1.1 Product Overview and Scope of Migraine Therapeutics
1.2 Classification of Migraine Therapeutics by Type
1.2.1 Global Migraine Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Migraine Therapeutics Revenue Market Share by Type in 2019
1.2.3 Specific Anti-migraine Drugs
1.2.4 Acute Therapies
1.2.5 Preventative Therapies
1.2.6 Other
1.3 Global Migraine Therapeutics Market by Application
1.3.1 Overview: Global Migraine Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 Global Migraine Therapeutics Market by Regions
1.4.1 Global Migraine Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Migraine Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Migraine Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Migraine Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Migraine Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Migraine Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Migraine Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline SWOT Analysis
2.2.4 GlaxoSmithKline Product and Services
2.2.5 GlaxoSmithKline Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Teva SWOT Analysis
2.3.4 Teva Product and Services
2.3.5 Teva Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Endo International
2.5.1 Endo International Details
2.5.2 Endo International Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Endo International SWOT Analysis
2.5.4 Endo International Product and Services
2.5.5 Endo International Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Abbott SWOT Analysis
2.7.4 Abbott Product and Services
2.7.5 Abbott Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson & Johnson SWOT Analysis
2.8.4 Johnson & Johnson Product and Services
2.8.5 Johnson & Johnson Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Amgen SWOT Analysis
2.9.4 Amgen Product and Services
2.9.5 Amgen Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Impax
2.10.1 Impax Details
2.10.2 Impax Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Impax SWOT Analysis
2.10.4 Impax Product and Services
2.10.5 Impax Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Kowa Pharmaceuticals America
2.11.1 Kowa Pharmaceuticals America Details
2.11.2 Kowa Pharmaceuticals America Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Kowa Pharmaceuticals America SWOT Analysis
2.11.4 Kowa Pharmaceuticals America Product and Services
2.11.5 Kowa Pharmaceuticals America Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Amirall
2.12.1 Amirall Details
2.12.2 Amirall Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Amirall SWOT Analysis
2.12.4 Amirall Product and Services
2.12.5 Amirall Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Bayer
2.13.1 Bayer Details
2.13.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Bayer SWOT Analysis
2.13.4 Bayer Product and Services
2.13.5 Bayer Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Revance Therapeutics
2.14.1 Revance Therapeutics Details
2.14.2 Revance Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Revance Therapeutics SWOT Analysis
2.14.4 Revance Therapeutics Product and Services
2.14.5 Revance Therapeutics Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Winston Pharmaceuticals
2.15.1 Winston Pharmaceuticals Details
2.15.2 Winston Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Winston Pharmaceuticals SWOT Analysis
2.15.4 Winston Pharmaceuticals Product and Services
2.15.5 Winston Pharmaceuticals Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.16 Ethypharm
2.16.1 Ethypharm Details
2.16.2 Ethypharm Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Ethypharm SWOT Analysis
2.16.4 Ethypharm Product and Services
2.16.5 Ethypharm Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.17 Eli Lilly
2.17.1 Eli Lilly Details
2.17.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Eli Lilly SWOT Analysis
2.17.4 Eli Lilly Product and Services
2.17.5 Eli Lilly Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.18 OptiNose
2.18.1 OptiNose Details
2.18.2 OptiNose Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 OptiNose SWOT Analysis
2.18.4 OptiNose Product and Services
2.18.3 OptiNose Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.19 AstraZeneca
2.19.1 AstraZeneca Details
2.19.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 AstraZeneca SWOT Analysis
2.19.4 AstraZeneca Product and Services
2.19.5 AstraZeneca Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.20 Novartis International
2.20.1 Novartis International Details
2.20.2 Novartis International Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Novartis International SWOT Analysis
2.20.4 Novartis International Product and Services
2.20.5 Novartis International Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.21 RedHill Biopharma
2.21.1 RedHill Biopharma Details
2.21.2 RedHill Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 RedHill Biopharma SWOT Analysis
2.21.4 RedHill Biopharma Product and Services
2.21.5 RedHill Biopharma Migraine Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.22 Valeant Pharma
2.23 Eisai
2.24 Biohaven Pharma
2.25 Bausch Health
2.26 NeurAxon
3 Market Competition, by Players
3.1 Global Migraine Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Migraine Therapeutics Players Market Share
3.2.2 Top 10 Migraine Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Migraine Therapeutics Revenue and Market Share by Regions
4.2 North America Migraine Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Migraine Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Migraine Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Migraine Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Migraine Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Migraine Therapeutics Revenue by Countries
5.1 North America Migraine Therapeutics Revenue by Countries (2015-2020)
5.2 USA Migraine Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Migraine Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Migraine Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Migraine Therapeutics Revenue by Countries
6.1 Europe Migraine Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Migraine Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Migraine Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Migraine Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Migraine Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Migraine Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Migraine Therapeutics Revenue by Countries
7.1 Asia-Pacific Migraine Therapeutics Revenue by Countries (2015-2020)
7.2 China Migraine Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Migraine Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Migraine Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Migraine Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Migraine Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Migraine Therapeutics Revenue by Countries
8.1 South America Migraine Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Migraine Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Migraine Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Migraine Therapeutics by Countries
9.1 Middle East & Africa Migraine Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Migraine Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Migraine Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Migraine Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Migraine Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Migraine Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Migraine Therapeutics Market Forecast by Type (2019-2024)
10.3 Specific Anti-migraine Drugs Revenue Growth Rate (2015-2025)
10.4 Acute Therapies Revenue Growth Rate (2015-2025)
10.5 Preventative Therapies Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Migraine Therapeutics Market Segment by Application
11.1 Global Migraine Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Migraine Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Household Use Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Migraine Therapeutics Market Size Forecast (2021-2025)
12.1 Global Migraine Therapeutics Market Size Forecast (2021-2025)
12.2 Global Migraine Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Migraine Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Migraine Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Migraine Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Migraine Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Migraine Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Migraine Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Migraine Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Migraine Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Migraine Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Allergan Corporate Information, Location and Competitors
Table 6. Allergan Migraine Therapeutics Major Business
Table 7. Allergan Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Allergan SWOT Analysis
Table 9. Allergan Migraine Therapeutics Product and Solutions
Table 10. Allergan Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. GlaxoSmithKline Corporate Information, Location and Competitors
Table 12. GlaxoSmithKline Migraine Therapeutics Major Business
Table 13. GlaxoSmithKline Migraine Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. GlaxoSmithKline SWOT Analysis
Table 15. GlaxoSmithKline Migraine Therapeutics Product and Solutions
Table 16. GlaxoSmithKline Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Teva Corporate Information, Location and Competitors
Table 18. Teva Migraine Therapeutics Major Business
Table 19. Teva Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Teva SWOT Analysis
Table 21. Teva Migraine Therapeutics Product and Solutions
Table 22. Teva Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Migraine Therapeutics Major Business
Table 25. Merck Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Migraine Therapeutics Product and Solutions
Table 28. Merck Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Endo International Corporate Information, Location and Competitors
Table 30. Endo International Migraine Therapeutics Major Business
Table 31. Endo International Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Endo International SWOT Analysis
Table 33. Endo International Migraine Therapeutics Product and Solutions
Table 34. Endo International Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Pfizer Corporate Information, Location and Competitors
Table 36. Pfizer Migraine Therapeutics Major Business
Table 37. Pfizer Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Pfizer SWOT Analysis
Table 39. Pfizer Migraine Therapeutics Product and Solutions
Table 40. Pfizer Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Abbott Corporate Information, Location and Competitors
Table 42. Abbott Migraine Therapeutics Major Business
Table 43. Abbott Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Abbott SWOT Analysis
Table 45. Abbott Migraine Therapeutics Product and Solutions
Table 46. Abbott Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Johnson & Johnson Corporate Information, Location and Competitors
Table 48. Johnson & Johnson Migraine Therapeutics Major Business
Table 49. Johnson & Johnson Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Johnson & Johnson SWOT Analysis
Table 51. Johnson & Johnson Migraine Therapeutics Product and Solutions
Table 52. Johnson & Johnson Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Amgen Corporate Information, Location and Competitors
Table 54. Amgen Migraine Therapeutics Major Business
Table 55. Amgen Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. Amgen SWOT Analysis
Table 57. Amgen Migraine Therapeutics Product and Solutions
Table 58. Amgen Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Impax Corporate Information, Location and Competitors
Table 60. Impax Migraine Therapeutics Major Business
Table 61. Impax Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. Impax SWOT Analysis
Table 63. Impax Migraine Therapeutics Product and Solutions
Table 64. Impax Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Kowa Pharmaceuticals America Corporate Information, Location and Competitors
Table 66. Kowa Pharmaceuticals America Migraine Therapeutics Major Business
Table 67. Kowa Pharmaceuticals America Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 68. Kowa Pharmaceuticals America SWOT Analysis
Table 69. Kowa Pharmaceuticals America Migraine Therapeutics Product and Solutions
Table 70. Kowa Pharmaceuticals America Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Amirall Corporate Information, Location and Competitors
Table 72. Amirall Migraine Therapeutics Major Business
Table 73. Amirall Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 74. Amirall SWOT Analysis
Table 75. Amirall Migraine Therapeutics Product and Solutions
Table 76. Amirall Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Bayer Corporate Information, Location and Competitors
Table 78. Bayer Migraine Therapeutics Major Business
Table 79. Bayer Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 80. Bayer SWOT Analysis
Table 81. Bayer Migraine Therapeutics Product and Solutions
Table 82. Bayer Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Revance Therapeutics Corporate Information, Location and Competitors
Table 84. Revance Therapeutics Migraine Therapeutics Major Business
Table 85. Revance Therapeutics Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 86. Revance Therapeutics SWOT Analysis
Table 87. Revance Therapeutics Migraine Therapeutics Product and Solutions
Table 88. Revance Therapeutics Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Winston Pharmaceuticals Corporate Information, Location and Competitors
Table 90. Winston Pharmaceuticals Migraine Therapeutics Major Business
Table 91. Winston Pharmaceuticals Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 92. Winston Pharmaceuticals SWOT Analysis
Table 93. Winston Pharmaceuticals Migraine Therapeutics Product and Solutions
Table 94. Winston Pharmaceuticals Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Ethypharm Corporate Information, Location and Competitors
Table 96. Ethypharm Migraine Therapeutics Major Business
Table 97. Ethypharm Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 98. Ethypharm SWOT Analysis
Table 99. Ethypharm Migraine Therapeutics Product and Solutions
Table 100. Ethypharm Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Eli Lilly Corporate Information, Location and Competitors
Table 102. Eli Lilly Migraine Therapeutics Major Business
Table 103. Eli Lilly Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 104. Eli Lilly SWOT Analysis
Table 105. Eli Lilly Migraine Therapeutics Product and Solutions
Table 106. Eli Lilly Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. OptiNose Migraine Therapeutics Type and Application
Table 108. OptiNose Migraine Therapeutics Major Business
Table 109. OptiNose Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 110. OptiNose SWOT Analysis
Table 111. OptiNose Migraine Therapeutics Product and Solutions
Table 112. OptiNose Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. AstraZeneca Corporate Information, Location and Competitors
Table 114. AstraZeneca Migraine Therapeutics Major Business
Table 115. AstraZeneca Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 116. AstraZeneca SWOT Analysis
Table 117. AstraZeneca Migraine Therapeutics Product and Solutions
Table 118. AstraZeneca Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Novartis International Corporate Information, Location and Competitors
Table 120. Novartis International Migraine Therapeutics Major Business
Table 121. Novartis International Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 122. Novartis International SWOT Analysis
Table 123. Novartis International Migraine Therapeutics Product and Solutions
Table 124. Novartis International Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. RedHill Biopharma Corporate Information, Location and Competitors
Table 126. RedHill Biopharma Migraine Therapeutics Major Business
Table 127. RedHill Biopharma Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 128. RedHill Biopharma SWOT Analysis
Table 129. RedHill Biopharma Migraine Therapeutics Product and Solutions
Table 130. RedHill Biopharma Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. Valeant Pharma Corporate Information, Location and Competitors
Table 132. Valeant Pharma Migraine Therapeutics Major Business
Table 133. Valeant Pharma Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 134. Valeant Pharma SWOT Analysis
Table 135. Valeant Pharma Migraine Therapeutics Product and Solutions
Table 136. Valeant Pharma Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Eisai Corporate Information, Location and Competitors
Table 138. Eisai Migraine Therapeutics Major Business
Table 139. Eisai Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 140. Eisai SWOT Analysis
Table 141. Eisai Migraine Therapeutics Product and Solutions
Table 142. Eisai Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 143. Biohaven Pharma Corporate Information, Location and Competitors
Table 144. Biohaven Pharma Migraine Therapeutics Major Business
Table 145. Biohaven Pharma Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 146. Biohaven Pharma SWOT Analysis
Table 147. Biohaven Pharma Migraine Therapeutics Product and Solutions
Table 148. Biohaven Pharma Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 149. Bausch Health Corporate Information, Location and Competitors
Table 150. Bausch Health Migraine Therapeutics Major Business
Table 151. Bausch Health Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 152. Bausch Health SWOT Analysis
Table 153. Bausch Health Migraine Therapeutics Product and Solutions
Table 154. Bausch Health Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 155. NeurAxon Corporate Information, Location and Competitors
Table 156. NeurAxon Migraine Therapeutics Major Business
Table 157. NeurAxon Migraine Therapeutics Total Revenue (USD Million) (2017-2018)
Table 158. NeurAxon SWOT Analysis
Table 159. NeurAxon Migraine Therapeutics Product and Solutions
Table 160. NeurAxon Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 161. Global Migraine Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 162. Global Migraine Therapeutics Revenue Share by Players (2015-2020)
Table 163. Global Migraine Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 164. Global Migraine Therapeutics Revenue Market Share by Regions (2015-2020)
Table 165. North America Migraine Therapeutics Revenue by Countries (2015-2020)
Table 166. North America Migraine Therapeutics Revenue Market Share by Countries (2015-2020)
Table 167. Europe Migraine Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 168. Asia-Pacific Migraine Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 169. South America Migraine Therapeutics Revenue by Countries (2015-2020)
Table 170. South America Migraine Therapeutics Revenue Market Share by Countries (2015-2020)
Table 171. Middle East and Africa Migraine Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 172. Middle East and Africa Migraine Therapeutics Revenue Market Share by Countries (2015-2020)
Table 173. Global Migraine Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 174. Global Migraine Therapeutics Revenue Share by Type (2015-2020)
Table 175. Global Migraine Therapeutics Revenue Forecast by Type (2021-2025)
Table 176. Global Migraine Therapeutics Revenue by Application (2015-2020)
Table 177. Global Migraine Therapeutics Revenue Share by Application (2015-2020)
Table 178. Global Migraine Therapeutics Revenue Forecast by Application (2021-2025)
Table 179. Global Migraine Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Migraine Therapeutics Picture
Figure 2. Global Migraine Therapeutics Revenue Market Share by Type in 2019
Figure 3. Specific Anti-migraine Drugs Picture
Figure 4. Acute Therapies Picture
Figure 5. Preventative Therapies Picture
Figure 6. Other Picture
Figure 7. Migraine Therapeutics Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Household Use Picture
Figure 11. Others Picture
Figure 12. Global Migraine Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Migraine Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Migraine Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Migraine Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Migraine Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Migraine Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Migraine Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Migraine Therapeutics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Migraine Therapeutics Revenue Market Share in 2019
Figure 21. Global Top 10 Players Migraine Therapeutics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Migraine Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Migraine Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 25. Global Migraine Therapeutics Revenue Market Share by Regions in 2018
Figure 26. North America Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Europe Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. South America Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. North America Migraine Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 32. North America Migraine Therapeutics Revenue Market Share by Countries in 2019
Figure 33. USA Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Canada Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Europe Migraine Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Migraine Therapeutics Revenue Market Share by Countries in 2019
Figure 38. Germany Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. UK Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. France Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Russia Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Italy Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Migraine Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Migraine Therapeutics Revenue Market Share by Countries in 2019
Figure 45. China Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Japan Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Korea Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. India Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. South America Migraine Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 51. South America Migraine Therapeutics Revenue Market Share by Countries in 2019
Figure 52. Brazil Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Migraine Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Migraine Therapeutics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. UAE Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Migraine Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. Global Migraine Therapeutics Revenue Share by Type (2015-2020)
Figure 61. Global Migraine Therapeutics Revenue Share by Type in 2019
Figure 62. Global Migraine Therapeutics Market Share Forecast by Type (2021-2025)
Figure 63. Global Specific Anti-migraine Drugs Revenue Growth Rate (2015-2020)
Figure 64. Global Acute Therapies Revenue Growth Rate (2015-2020)
Figure 65. Global Preventative Therapies Revenue Growth Rate (2015-2020)
Figure 66. Global Other Revenue Growth Rate (2015-2020)
Figure 67. Global Migraine Therapeutics Revenue Share by Application (2015-2020)
Figure 68. Global Migraine Therapeutics Revenue Share by Application in 2019
Figure 69. Global Migraine Therapeutics Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Clinics Revenue Growth Rate (2015-2020)
Figure 72. Global Household Use Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Migraine Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Migraine Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Migraine Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Migraine Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. Europe Migraine Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Migraine Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. South America Migraine Therapeutics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Migraine Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---